Supplementary Table 1. List of chemotherapeutic agents contained in the different schemes

Baseline characteristics of

Patients diagnosed with advanced chronic or aggressive periodontitis were included in the study, provided that they were 40 years of age at the initial examination and had

Data in the literature are controversial in this respect: Julian et al. [1] did not find a significant correlation between PTH levels at time of transplanta- tion and lumbar bone

The “Seven Good Reasons for Mobile Agents” [3] appear to be far- reaching: mobile agents reduce network load, overcome network latency, encapsulate protocols, work autonomously

Examining NT5C1A overexpressing PSCs, we were able to demonstrate significantly reduced intracellular levels of dFdCTP (Hessmann & Patzak et al., 2018),

Use of the agents sodium fluoride (NaF), tricalcium phosphate (Ca 3 PO 4 ), titanium tetrafluoride (TiF 4 ), Tooth Mousse (CPP-ACP), MI Paste Plus (CPP-ACP), and NovaMin

40 Irbesartan/Amlodipine Besilate Combined Drug 41 Irbesartan/Trichlormethiazide Combined Drug 42 Labetalol Hydrochloride. 43 Lisinopril Hydrate 44

Olorofim shows great promise for the treatment of resistant mold infections. It possesses activity against highly resistant and cryptic Aspergillus species including A. In